Related Experiment Video
Updated: Sep 20, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
A two-phase approach to identifying HFpEF in heart failure patients: Risk score evaluation and decision tree
Izabella Uchmanowicz1,2, Magdalena Lisiak1, Piotr Ponikowski3
1Department of Nursing, Division of Research Methodology, Faculty of Nursing and Midwifery, Wroclaw Medical University, Wroclaw, Poland.
Aims:
Heart failure (HF) with preserved ejection fraction (HFpEF) poses significant diagnostic challenges due to its complex aetiology and overlapping symptoms with other HF types. The heterogeneity of HFpEF, compounded by frequent comorbidities, complicates diagnosis. This study aimed to enhance HFpEF prediction through a two-phase approach: a simplified risk score and a decision tree model.
Methods And Results:
In Phase 1, an 8-point risk score based on accessible clinical parameters was developed. In Phase 2, we conducted comprehensive predictive modelling using decision tree analysis. Data from 560 HF patients were analysed. It achieved an accuracy of 63.13% (sensitivity: 62.87%, specificity: 54.24%). In Phase 2, a decision tree model using broader clinical variables improved accuracy to 73.04% (sensitivity: 53.89%, specificity: 81.17%).
Conclusions:
This dual framework provides tools for both quick screening and detailed risk stratification in various clinical settings.
More Related Videos
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies